A specific inhibitor of FXa is XARELTO. It can function without a cofactor like anti-thrombin III. Free FXa and prothrombinase activity are both inhibited by rivaroxaban. Although rivaroxaban does not directly affect platelet aggregation, it does indirectly prevent thrombin-induced platelet aggregation. The production of thrombin is reduced by rivaroxaban’s inhibition of FXa.
*Products will not be offered for sale in countries where valid Patents are in force.
* It is the responsibility of the buyer to comply with the above.
|API Name :||Rivaroxaban|
|CAS Number :||366789-02-8|
|Packing Type :||Drum|
|Therapeutic use :||Anticoagulant|
|Product MOQ :||5 kg|